CytomX Therapeutics, Inc. (CTMX)
2.73
+0.04
(+1.49%)
USD |
NASDAQ |
Sep 16, 14:56
CytomX Therapeutics Total Assets (Quarterly) : 381.23M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 381.23M |
| March 31, 2026 | 359.36M |
| December 31, 2025 | 152.50M |
| September 30, 2025 | 158.25M |
| June 30, 2025 | 175.06M |
| March 31, 2025 | 98.50M |
| December 31, 2024 | 122.64M |
| September 30, 2024 | 138.98M |
| June 30, 2024 | 159.22M |
| March 31, 2024 | 184.69M |
| December 31, 2023 | 205.15M |
| September 30, 2023 | 221.17M |
| June 30, 2023 | 209.18M |
| March 31, 2023 | 234.63M |
| December 31, 2022 | 264.49M |
| September 30, 2022 | 226.49M |
| June 30, 2022 | 260.09M |
| March 31, 2022 | 296.82M |
| December 31, 2021 | 344.02M |
| September 30, 2021 | 371.23M |
| June 30, 2021 | 402.44M |
| March 31, 2021 | 434.16M |
| December 31, 2020 | 364.20M |
| Date | Value |
|---|---|
| September 30, 2020 | 375.18M |
| June 30, 2020 | 402.48M |
| March 31, 2020 | 436.66M |
| December 31, 2019 | 341.28M |
| September 30, 2019 | 372.54M |
| June 30, 2019 | 405.28M |
| March 31, 2019 | 444.51M |
| December 31, 2018 | 458.24M |
| September 30, 2018 | 482.73M |
| June 30, 2018 | 376.94M |
| March 31, 2018 | 376.46M |
| December 31, 2017 | 398.04M |
| September 30, 2017 | 387.04M |
| June 30, 2017 | 351.86M |
| March 31, 2017 | 177.88M |
| December 31, 2016 | 199.44M |
| September 30, 2016 | 192.88M |
| June 30, 2016 | 206.86M |
| March 31, 2016 | 192.03M |
| December 31, 2015 | 197.69M |
| September 30, 2015 | 124.86M |
| June 30, 2015 | 134.50M |
| March 31, 2015 | 67.65M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 41.73B |
| ACADIA Pharmaceuticals, Inc. | 1.743B |
| Alnylam Pharmaceuticals, Inc. | 5.559B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 79.16M |
| Shareholders Equity (Quarterly) | 302.07M |
| Debt to Equity Ratio | 0.0189 |
| Current Ratio | 9.361 |
| Net Debt Paydown Yield | 0.06% |